This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Larrea, F. Articles by Alarcón-Segovia, D. Search for Related Content PubMed PubMed Citation Articles by Larrea, F. Articles by Alarcón-Segovia, D.

A Bioactive 60-Kilodalton Prolactin Species Is Preferentially Secreted in Cultures of Mitogen-Stimulated and Nonstimulated Peripheral Blood Mononuclear Cells from Subjects with Systemic Lupus Erythematosus¹

Departments of Reproductive Biology (F.L., V.C., G.Q., C.C.) and Immunology and Rheumatology (A.M.-C., J.A.-V., D.A.-S.), Instituto Nacional de la Nutrición Salvador Zubirán, Mexico City 14000, Mexico

Address all correspondence and requests for reprints to: Fernando Larrea, M.D., Department of Reproductive Biology, Instituto Nacional de la Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Mexico City 14000, Mexico.

We have evaluated the production of PRL by human peripheral mononuclear cells (PBMNC) from normal subjects and patients with systemic lupus erythematosus (SLE). Conditioned medium prepared from basal and Con-A-stimulated PBMNC was assessed for the presence of PRL-like by its ability to stimulate growth of PRL-responsive Nb2 rat lymphoma cells. In the presence or absence of Con-A, SLE PBMNC secrete significantly higher (P < 0.001) amounts of bioactive PRL-like species than normal cells. Growth of Nb2 cells by conditioned medium was inhibited with specific antiserum to human PRL. Western blotting using a polyclonal antibody to human PRL revealed a single 60-kDa PRL-like species in both normal and SLE PBMNC extracts, the immunoreactivity of which was preferentially found in SLE subjects. With the use of reverse transcription-PCR an expected 633-bp band was observed, and its similarity to pituitary PRL was further confirmed by Southern blot analysis with human PRL complementary DNA as a probe. We conclude that a high molecular mass PRL-like species is synthesized and secreted by PBMNC, and patients with SLE have an increased secretion of lymphocyte-derived PRL-like material.

This article has been cited by other articles:

				J. Zhang, R. Sun, and Z. Tian Human Prolactin Promotes Human Secondary Immunoglobulin Response in Human/SCID Mouse Chimeras Clin. Vaccine Immunol., January 1, 2007; 14(1): 60 - 64. [Abstract] [Full Text] [PDF]

				S. Gerlo, P. Verdood, B. Gellersen, E. L. Hooghe-Peters, and R. Kooijman Mechanism of Prostaglandin (PG)E2-Induced Prolactin Expression in Human T Cells: Cooperation of Two PGE2 Receptor Subtypes, E-Prostanoid (EP) 3 and EP4, Via Calcium- and Cyclic Adenosine 5'-Monophosphate-Mediated Signaling Pathways J. Immunol., November 15, 2004; 173(10): 5952 - 5962. [Abstract] [Full Text] [PDF]

				M Garcia, M E Colombani-Vidal, C C Zylbersztein, A Testi, J Marcos, A Arturi, J Babini, and H E Scaglia Analysis of molecular heterogeneity of prolactin in human systemic lupus erythematosus Lupus, August 1, 2004; 13(8): 575 - 583. [Abstract] [PDF]

				I Mendez, J Alcocer-Varela, A Parra, A Lava-Zavala, D A de la Cruz, D Alarcon-Segovia, and F Larrea Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin Lupus, January 1, 2004; 13(1): 45 - 53. [Abstract] [PDF]

				L Daza, C Lavalle, C Duarte, R Huerta, and J Moreno Lack of association between hyperprolactinemia and soluble IL-2 receptor levels in systemic lupus erythematosus Lupus, February 1, 2003; 12(2): 107 - 111. [Abstract] [PDF]

				D W Montgomery Prolactin production by immune cells Lupus, October 1, 2001; 10(10): 665 - 675. [Abstract] [PDF]

				A Stevens, D W Ray, J Worthington, and J R. Davis Polymorphisms of the human prolactin gene--implications for production of lymphocyte prolactin and systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 676 - 683. [Abstract] [PDF]

				L J Jara, O Vera-Lastra, J M Miranda, M Alcala, and J Alvarez-Nemegyci Prolactin in human systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 748 - 756. [Abstract] [PDF]

				A. Leanos-Miranda, D. Pascoe-Lira, K. A. Chavez-Rueda, and F. Blanco-Favela Persistence of Macroprolactinemia Due to Antiprolactin Autoantibody before, during, and after Pregnancy in a Woman with Systemic Lupus Erythematosus J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2619 - 2624. [Abstract] [Full Text] [PDF]

				G. La Montagna, A. Baruffo, D. Pasquali, A. Bellastella, G. Tirri, and A. A. Sinisi Assessment of pituitary gonadotropin release to gonadotropin releasing hormone/thyroid-stimulating hormone stimulation in women with systemic sclerosis Rheumatology, March 1, 2001; 40(3): 310 - 314. [Abstract] [Full Text] [PDF]

				J M Miranda, R E Prieto, R Paniagua, G Garcia, D Amato, L Barile, and L J Jara Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis Lupus, July 1, 1998; 7(6): 387 - 391. [Abstract] [PDF]

				J Rovensky, S Blazickova, L Rauovaa, D Jezova, J Koska, J Lukac, and M Vigas The hypothalamic-pituitary response in SLE. Regulation of prolactin, growth hormone and cortisol release Lupus, July 1, 1998; 7(6): 409 - 413. [Abstract] [PDF]

				J Alvarez-Nemegyei, A Cobarrubias-Cobos, F Escalante-Triay, J Sosa-Muuoz, J M Miranda, and L J Jara Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study Lupus, July 1, 1998; 7(6): 414 - 419. [Abstract] [PDF]